Jinhai Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Jinhai Wang has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
Ennan Guan
Laboratory of Immunology, Division of Therapeutic Proteins, Office of Biotechnology Products, Center for Drug Evaluation and Research, Food and Drug Administration, Bethesda, Maryland 20892
4 shared publicationsGregory Roderiquez
Laboratory of Immunology, Division of Therapeutic Proteins, Office of Biotechnology Products, Center for Drug Evaluation and Research, Food and Drug Administration, Bethesda, Maryland 20892
4 shared publicationsMichael A Norcross
Laboratory of Gene Regulation, Division of Therapeutic Proteins, Center for Biologics Evaluation and Research, Food and Drug Administration, National Institutes of Health , Bethesda, MD 20892
2 shared publicationsMichael A. Norcross
Laboratory of Immunology, Division of Therapeutic Proteins, Office of Biotechnology Products, Center for Drug Evaluation and Research, Food and Drug Administration, Bethesda, Maryland 20892
2 shared publicationsRaymond Alvarez
Laboratory of Immunology, Division of Therapeutic Proteins, Office of Biotechnology Products, Center for Drug Evaluation and Research, Food and Drug Administration, Bethesda, Maryland 20892
2 shared publications- Ennan Guan
Division of Therapeutic Proteins, Center for Drug Evaluation and Research, Food and Drug Administration, Bethesda, Maryland 20892, USA
1 shared publication
Latest Publications
- 11 August 2004
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 93 (4) , 753-760
Constitutive association of cell surface CCR5 and CXCR4 in the presence of CD4
Chemokine receptors CCR5 and CXCR4 are the major coreceptors of HIV‐1 infection and also play fundamental roles in leukocyte trafficking, metastasis, angiogenesis, and embyogenesis. Here, we show that transfection of CCR5 into CXCR4 and CD4 expressing 3T3 cells enhances the cell surface level of CXCR4. In CCR5 high expressing cells, cell surface level of CXCR4 was incompletely modulated in the presence of the CXCR4 ligand CXCL12/SDF‐1α. CCR5 was resistant to ligand‐dependent modulation with the CCR5 ligand CCL5/RANTES. Confocal laser microscopy revealed that CCR5 was colocalized with CXCR4 on the cell surface. In CD4 expressing CCR5 and CXCR4 double positive NIH 3T3 cells, immunoprecipitation followed by Western blot analysis revealed that CCR5 was associated with CXCR4 and CD4. CXCR4 and CCR5 were not co‐immunoprecipitated in cells expressing CCR5 and CXCR4 but without CD4 expression. Compared to NIH 3T3CD4 cells expressing CXCR4, the entry of an HIV‐1 X4 isolate (HCF) into NIH 3T3CD4 expressing both CXCR4 and CCR5 was reduced. Our data indicate that chemokine receptors interact with each other, which may modulate chemokine–chemokine receptor interactions and HIV‐1 coreceptor functions. Published 2004 Wiley‐Liss, Inc.
- 11 August 2004
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 93 (4) , 753-760
Constitutive association of cell surface CCR5 and CXCR4 in the presence of CD4
Chemokine receptors CCR5 and CXCR4 are the major coreceptors of HIV‐1 infection and also play fundamental roles in leukocyte trafficking, metastasis, angiogenesis, and embyogenesis. Here, we show that transfection of CCR5 into CXCR4 and CD4 expressing 3T3 cells enhances the cell surface level of CXCR4. In CCR5 high expressing cells, cell surface level of CXCR4 was incompletely modulated in the presence of the CXCR4 ligand CXCL12/SDF‐1α. CCR5 was resistant to ligand‐dependent modulation with the CCR5 ligand CCL5/RANTES. Confocal laser microscopy revealed that CCR5 was colocalized with CXCR4 on the cell surface. In CD4 expressing CCR5 and CXCR4 double positive NIH 3T3 cells, immunoprecipitation followed by Western blot analysis revealed that CCR5 was associated with CXCR4 and CD4. CXCR4 and CCR5 were not co‐immunoprecipitated in cells expressing CCR5 and CXCR4 but without CD4 expression. Compared to NIH 3T3CD4 cells expressing CXCR4, the entry of an HIV‐1 X4 isolate (HCF) into NIH 3T3CD4 expressing both CXCR4 and CCR5 was reduced. Our data indicate that chemokine receptors interact with each other, which may modulate chemokine–chemokine receptor interactions and HIV‐1 coreceptor functions. Published 2004 Wiley‐Liss, Inc.
- Open Access
- 1 December 2001
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 276 (52) , 49236-49243
Role of Tyrosine Phosphorylation in Ligand-independent Sequestration of CXCR4 in Human Primary Monocytes-Macrophages
- 1 December 2001
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 276 (52) , 49236-49243
Open AccessRole of Tyrosine Phosphorylation in Ligand-independent Sequestration of CXCR4 in Human Primary Monocytes-Macrophages
- 15 September 2001
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 167 (6) , 3360-3366
Synergistic Induction of Apoptosis in Primary CD4+ T Cells by Macrophage-Tropic HIV-1 and TGF-β1
Depletion of CD4+ T lymphocytes is a central immunological characteristic of HIV-1 infection. Although the mechanism of such CD4+ cell loss following macrophage-tropic (R5) HIV-1 infection remains unclear, interactions between viral and host cell factors are thought to play an important role in the pathogenesis of HIV-1 disease. Based on the observation that TGF-β1 enhanced expression of HIV chemokine coreceptors, the role of this host factor in virus effects was investigated using PBLs cultured in a nonmitogen-added system in the absence or presence of TGF-β1. Most CD4 cells in such cultures had the phenotype CD25−CD69−DR−Ki67− and were CD45RObrightCD45RAdim. Cultured cells had increased expression of CCR5 and CXCR4 and supported both HIV-1 entry and completion of viral reverse transcription. Virus production by cells cultured in the presence of IL-2 was inhibited by TGF-β1, and this inhibition was accompanied by a loss of T cells from the culture and an increase in CD4+ T cell apoptosis. Whereas R5X4 and X4 HIV-1 infection was sufficient to induce T cell apoptosis, R5 HIV-1 failed to induce apoptosis of PBLs in the absence of TGF-β1 despite the fact that R5 HIV-1 depletes CD4+ T cells in vivo. Increased apoptosis with HIV and TGF-β1 was associated with reduced levels of Bcl-2 and increased expression of apoptosis-inducing factor, caspase-3, and cleavage of BID, c-IAP-1, and X-linked inhibitor of apoptosis. These results show that TGF-β1 promotes depletion of CD4+ T cells after R5 HIV-1 infection by inducing apoptosis and suggest that TGF-β1 might contribute to the pathogenesis of HIV-1 infection in vivo.
- 15 September 2001
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 167 (6) , 3360-3366
Synergistic Induction of Apoptosis in Primary CD4+ T Cells by Macrophage-Tropic HIV-1 and TGF-β1
Depletion of CD4+ T lymphocytes is a central immunological characteristic of HIV-1 infection. Although the mechanism of such CD4+ cell loss following macrophage-tropic (R5) HIV-1 infection remains unclear, interactions between viral and host cell factors are thought to play an important role in the pathogenesis of HIV-1 disease. Based on the observation that TGF-β1 enhanced expression of HIV chemokine coreceptors, the role of this host factor in virus effects was investigated using PBLs cultured in a nonmitogen-added system in the absence or presence of TGF-β1. Most CD4 cells in such cultures had the phenotype CD25−CD69−DR−Ki67− and were CD45RObrightCD45RAdim. Cultured cells had increased expression of CCR5 and CXCR4 and supported both HIV-1 entry and completion of viral reverse transcription. Virus production by cells cultured in the presence of IL-2 was inhibited by TGF-β1, and this inhibition was accompanied by a loss of T cells from the culture and an increase in CD4+ T cell apoptosis. Whereas R5X4 and X4 HIV-1 infection was sufficient to induce T cell apoptosis, R5 HIV-1 failed to induce apoptosis of PBLs in the absence of TGF-β1 despite the fact that R5 HIV-1 depletes CD4+ T cells in vivo. Increased apoptosis with HIV and TGF-β1 was associated with reduced levels of Bcl-2 and increased expression of apoptosis-inducing factor, caspase-3, and cleavage of BID, c-IAP-1, and X-linked inhibitor of apoptosis. These results show that TGF-β1 promotes depletion of CD4+ T cells after R5 HIV-1 infection by inducing apoptosis and suggest that TGF-β1 might contribute to the pathogenesis of HIV-1 infection in vivo.
- Open Access
- 1 July 2001
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 167 (1) , 289-295
Human Notch-1 Inhibits NF-κB Activity in the Nucleus Through a Direct Interaction Involving a Novel Domain
Notch participates in diverse cell fate decisions throughout embryonic development and postnatal life. Members of the NF-κB/Rel family of transcription factors are involved in the regulation of a variety of genes important for immune function. The biological activity of the NF-κB transcription factors is controlled by IκB proteins. Our previous work demonstrated that an intracellular, constitutively active form of human Notch-1/translocation-associated Notch homologue-1 (NotchIC) functions as an IκB molecule with specificity for the NF-κB p50 subunit and physically interacts with NF-κB in T cells. In the current study, we investigated the roles of different domains of NotchIC in the regulation of NF-κB-directed gene expression and NF-κB DNA binding activity. We found that NotchIC localizes to the nucleus and that a region in the N-terminal portion of NotchIC, not the six ankyrin repeats, is responsible for the inhibitory effects of Notch on NF-κB-directed gene expression and NF-κB DNA binding activity. The N-terminal portion of NotchIC inhibited p50 DNA binding and interacted specifically with p50 subunit, not p65 of NF-κB. The interaction between Notch and NF-κB indicates that in addition to its role in the development of the immune system, Notch-1 may also have critical functions in the immune response, inflammation, viral infection, and apoptosis through control of NF-κB-mediated gene expression.
- 1 July 2001
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 167 (1) , 289-295
Open AccessHuman Notch-1 Inhibits NF-κB Activity in the Nucleus Through a Direct Interaction Involving a Novel Domain
Notch participates in diverse cell fate decisions throughout embryonic development and postnatal life. Members of the NF-κB/Rel family of transcription factors are involved in the regulation of a variety of genes important for immune function. The biological activity of the NF-κB transcription factors is controlled by IκB proteins. Our previous work demonstrated that an intracellular, constitutively active form of human Notch-1/translocation-associated Notch homologue-1 (NotchIC) functions as an IκB molecule with specificity for the NF-κB p50 subunit and physically interacts with NF-κB in T cells. In the current study, we investigated the roles of different domains of NotchIC in the regulation of NF-κB-directed gene expression and NF-κB DNA binding activity. We found that NotchIC localizes to the nucleus and that a region in the N-terminal portion of NotchIC, not the six ankyrin repeats, is responsible for the inhibitory effects of Notch on NF-κB-directed gene expression and NF-κB DNA binding activity. The N-terminal portion of NotchIC inhibited p50 DNA binding and interacted specifically with p50 subunit, not p65 of NF-κB. The interaction between Notch and NF-κB indicates that in addition to its role in the development of the immune system, Notch-1 may also have critical functions in the immune response, inflammation, viral infection, and apoptosis through control of NF-κB-mediated gene expression.
- Open Access
- 1 December 1999
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 163 (11) , 5763-5769
Inhibition of CCR5 Expression by IL-12 Through Induction of β-Chemokines in Human T Lymphocytes
IL-12 induces initiation of the differentiation of naive CD4+ T lymphocytes into Th1 cells and is important for the control of cell-mediated immunity. β-Chemokines serve to attract various types of blood leukocytes to sites of infection and inflammation. The specific receptor for the β-chemokines (macrophage-inflammatory protein (MIP)-1α, MIP-1β, and RANTES), CCR5, also functions as the primary coreceptor for macrophage-tropic isolates of HIV-1. IL-12, but not IL-4, IL-10, or IL-13, now has been shown to down-modulate the surface expression of CCR5 induced by IL-2 on both CD4+ and CD8+ T lymphocytes. Decreased CCR5 surface expression was not secondary to transcriptional inhibition, given that CCR5 mRNA was enhanced in cells cultured in IL-12/IL-2 compared with those cultured in IL-2 only. The effect of IL-12 in down-modulation of CCR5 surface expression was shown to be mediated by soluble factors secreted from the T cells. Rapid and transient intracellular Ca2+ mobilization was induced in monocytes by IL-12-induced supernatants, which desensitized the response of monocytes to MIP-1α, but not their response to stromal cell-derived factor-1α. Neutralization with specific Abs identified these factors as MIP-1α and MIP-1β from most donors. IL-4, IL-10, IFN-γ, and IL-18 primarily inhibited MIP-1β secretion and also weakly suppressed MIP-1α secretion. HIV-1 replication was inhibited in IL-2/IL-12-containing cultures that correlated with chemokine and chemokine-receptor levels. These data suggest that the effects of IL-12 on β-chemokine production and chemokine-receptor expression may contribute to the immunomodulatory activities of IL-12 and may have potential therapeutic relevance in controlling HIV-1 replication.
- 1 December 1999
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 163 (11) , 5763-5769
Open AccessInhibition of CCR5 Expression by IL-12 Through Induction of β-Chemokines in Human T Lymphocytes
IL-12 induces initiation of the differentiation of naive CD4+ T lymphocytes into Th1 cells and is important for the control of cell-mediated immunity. β-Chemokines serve to attract various types of blood leukocytes to sites of infection and inflammation. The specific receptor for the β-chemokines (macrophage-inflammatory protein (MIP)-1α, MIP-1β, and RANTES), CCR5, also functions as the primary coreceptor for macrophage-tropic isolates of HIV-1. IL-12, but not IL-4, IL-10, or IL-13, now has been shown to down-modulate the surface expression of CCR5 induced by IL-2 on both CD4+ and CD8+ T lymphocytes. Decreased CCR5 surface expression was not secondary to transcriptional inhibition, given that CCR5 mRNA was enhanced in cells cultured in IL-12/IL-2 compared with those cultured in IL-2 only. The effect of IL-12 in down-modulation of CCR5 surface expression was shown to be mediated by soluble factors secreted from the T cells. Rapid and transient intracellular Ca2+ mobilization was induced in monocytes by IL-12-induced supernatants, which desensitized the response of monocytes to MIP-1α, but not their response to stromal cell-derived factor-1α. Neutralization with specific Abs identified these factors as MIP-1α and MIP-1β from most donors. IL-4, IL-10, IFN-γ, and IL-18 primarily inhibited MIP-1β secretion and also weakly suppressed MIP-1α secretion. HIV-1 replication was inhibited in IL-2/IL-12-containing cultures that correlated with chemokine and chemokine-receptor levels. These data suggest that the effects of IL-12 on β-chemokine production and chemokine-receptor expression may contribute to the immunomodulatory activities of IL-12 and may have potential therapeutic relevance in controlling HIV-1 replication.